# Walgreens Boots Alliance, Inc. – Consensus ‘hold’ rating and 45.6% Upside Potential

- Link: https://www.directorstalkinterviews.com/walgreens-boots-alliance-inc.consensus-hold-rating-and-45.6-upside-potential/4121127868
- Published: 2023-09-20T14:39:22+01:00
- Author: Charlotte Edwards

**Walgreens Boots Alliance, Inc.** which can be found using ticker (WBA) now have
13 confirmed analysts covering the stock with the consensus suggesting a rating 
of ‘hold’. The range between the high target price and low target price is between
45 and 26 suggesting an average Analsyt target price of $32.31. Now with the previous
closing price of $22.19 this is indicating there is a potential upside of 45.6%.
It’s also worth noting that there is a 50 day moving average of $27.15 and the 200
day moving average is $32.79. The market cap for the company is 19.16B. The stock
price is currently at: 22.03 USD

 The potential market cap would be $27,891,974,200 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 157.64 and
a 0.67% return on assets.

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing
company. The Company operates through three segments: U.S. Retail Pharmacy, International,
and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens
business, which includes the operations of retail drug stores, health and wellness
services, and specialty and home delivery pharmacy services, and its equity method
investment in AmerisourceBergen. Its International segment consists of pharmacy-
led health and beauty retail businesses outside the United States and a pharmaceutical
wholesaling and distribution business in Germany. Its portfolio of consumer brands
include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico
and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-
enabled healthcare business that engages consumers through a personalized, omni-
channel experience across the care journey.

Share on: